02.09.2021Orphalan announces FDA acceptance for filing of New Drug Application (NDA) for trientine tetrahydrochloride (TETA 4HCl) for the treatment of Wilson’s Disease

Press Release
13.07.2021Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158

Press Release
07.07.2021NeRRe Therapeutics raises £20 million in a Series B2 financing round

Press Release
28.06.2021Amphista Therapeutics Expands Research Team by Appointing Martin O’Rourke as Head of Drug Discovery and James Osborne as Director of Chemistry

Press Release
23.06.2021Aleta Biotherapeutics and Cancer Research UK collaborate to advance blood cancer therapy into the clinic

Press Release
17.06.2021Aura Biosciences Assembles New Bladder Cancer Focused Scientific Advisory Board

Press Release
08.06.2021Aura Biosciences Appoints Sapna Srivastava, Ph.D., to its Board of Directors

In The News
14.04.2021Highlight Therapeutics to present data from Phase 2 immunotherapy studies of liver metastases and melanoma data at AACR Virtual Annual Meeting 202

Press Release
14.04.2021Aura Biosciences Announces Publication of Data in Cancer Immunology Research Supporting the Immune Mediated Mechanism of Action of the Virus-Like Drug Conjugate (VDC) Technology Platform with Broad Application in Cancer Treatment

Press Release
12.04.2021Francesco Maria Lavino appointed Chief Executive Officer of F2G Ltd

Press Release